Hansa Biopharma Hosts Virtual Event with Transplant Surgeons
Hansa Biopharma AB announced a virtual event featuring distinguished transplant surgeons to discuss clinical practice and imlifidase Phase 3 results.
The event, scheduled for November 12, 2025, at 9:00 AM EST, will feature Professor Robert Montgomery and Professor Matthew Cooper, who will share insights into the medical journey of highly sensitized patients awaiting a kidney transplant.
They will also provide perspectives on the clinical relevance of the topline results from the US Phase 3 ConfIdeS study.
No specific quotes are available in the given text.
For more information, contact +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT.
Author's summary: Hansa Biopharma hosts a virtual event on kidney transplant.